Research unit
Project number
43914.1 IP-LS
Project title
New therapy for targeting pathogen-dependent immune subversion mechanisms for Leishmaniasis treatment.
Project status In Process
Start date 01.07.2020
End date 01.01.2023
Granted total costs 345'716.00  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
Research disciplines
100 % B007 Medicine (human and vertebrates)

Last modification of the project